Home » Topics » Regulatory

Regulatory
RSS

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

New formulation of Agouron's Viracept approved in U.S.

March 10, 2000

Pharmacia & Upjohn submits applications for once-daily Detrol formulation

March 10, 2000

AMBI to receive patent for use of calcium taurate with antihypertensive agents

March 10, 2000

The FDA approves once-daily Singulair tablet for treatment of asthma in young children

March 9, 2000

Solid oral formulations of eprosartan with enhanced bioavailability

March 9, 2000

Use of secretin for autism receives broad patent coverage

March 7, 2000

European mutual recognition approval obtained for candesartan/HCTZ combination

March 7, 2000

Noven successfully completes phase II study of MethyPatch for treatment of ADHD

March 3, 2000

Novantrone moves one step closer to approval for MS

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.